206 related articles for article (PubMed ID: 17960351)
1. [Therapy of multiple myeloma: indications and options].
Peest D; Ganser A
Internist (Berl); 2007 Dec; 48(12):1343-8. PubMed ID: 17960351
[TBL] [Abstract][Full Text] [Related]
2. Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: a randomized controlled trial.
Palumbo A; Bringhen S; Rossi D; Cavalli M; Larocca A; Ria R; Offidani M; Patriarca F; Nozzoli C; Guglielmelli T; Benevolo G; Callea V; Baldini L; Morabito F; Grasso M; Leonardi G; Rizzo M; Falcone AP; Gottardi D; Montefusco V; Musto P; Petrucci MT; Ciccone G; Boccadoro M
J Clin Oncol; 2010 Dec; 28(34):5101-9. PubMed ID: 20940200
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan-prednisone (VMP) in untreated multiple myeloma patients with renal impairment.
Morabito F; Gentile M; Mazzone C; Rossi D; Di Raimondo F; Bringhen S; Ria R; Offidani M; Patriarca F; Nozzoli C; Petrucci MT; Benevolo G; Vincelli I; Guglielmelli T; Grasso M; Marasca R; Baldini L; Montefusco V; Musto P; Cascavilla N; Majolino I; Musolino C; Cavo M; Boccadoro M; Palumbo A
Blood; 2011 Nov; 118(22):5759-66. PubMed ID: 21951682
[TBL] [Abstract][Full Text] [Related]
4. Novel therapies in multiple myeloma for newly diagnosed nontransplant candidates.
Kristinsson SY; Landgren O; Rajkumar VS
Cancer J; 2009; 15(6):473-8. PubMed ID: 20010166
[TBL] [Abstract][Full Text] [Related]
5. [Complications and managements in treatment of melphalan, prednisone and new agents].
Ishida T
Nihon Rinsho; 2015 Feb; 73 Suppl 2():649-52. PubMed ID: 25831841
[No Abstract] [Full Text] [Related]
6. Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myeloma.
Palumbo A; Ambrosini MT; Benevolo G; Pregno P; Pescosta N; Callea V; Cangialosi C; Caravita T; Morabito F; Musto P; Bringhen S; Falco P; Avonto I; Cavallo F; Boccadoro M; ;
Blood; 2007 Apr; 109(7):2767-72. PubMed ID: 17148584
[TBL] [Abstract][Full Text] [Related]
7. Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival.
Palumbo A; Bringhen S; Larocca A; Rossi D; Di Raimondo F; Magarotto V; Patriarca F; Levi A; Benevolo G; Vincelli ID; Grasso M; Franceschini L; Gottardi D; Zambello R; Montefusco V; Falcone AP; Omedé P; Marasca R; Morabito F; Mina R; Guglielmelli T; Nozzoli C; Passera R; Gaidano G; Offidani M; Ria R; Petrucci MT; Musto P; Boccadoro M; Cavo M
J Clin Oncol; 2014 Mar; 32(7):634-40. PubMed ID: 24449241
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous involvement in multiple myeloma and bortezomib.
Siniscalchi A; Fratoni S; Santeusanio G; Del Poeta G; de Fabritiis P; Caravita T
Ann Hematol; 2009 Nov; 88(11):1137-9. PubMed ID: 19259673
[No Abstract] [Full Text] [Related]
9. Bortezomib plus melphalan and prednisone for multiple myeloma.
Tsubokura M; Kami M; Komatsu T
N Engl J Med; 2008 Dec; 359(24):2613; author reply 2613-4. PubMed ID: 19090031
[No Abstract] [Full Text] [Related]
10. First-line treatment of elderly multiple myeloma patients.
Palumbo A
Clin Adv Hematol Oncol; 2010 Aug; 8(8):529-30. PubMed ID: 20966887
[No Abstract] [Full Text] [Related]
11. Bortezomib plus melphalan and prednisone for multiple myeloma.
Avvisati G
N Engl J Med; 2008 Dec; 359(24):2613; author reply 2613-4. PubMed ID: 19090032
[No Abstract] [Full Text] [Related]
12. Frontline Therapy for Patients with Multiple Myeloma not Eligible for Stem Cell Transplantation.
Moreau P; Hulin C; Facon T
Hematol Oncol Clin North Am; 2014 Oct; 28(5):829-38. PubMed ID: 25212885
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of once-weekly bortezomib in multiple myeloma patients.
Bringhen S; Larocca A; Rossi D; Cavalli M; Genuardi M; Ria R; Gentili S; Patriarca F; Nozzoli C; Levi A; Guglielmelli T; Benevolo G; Callea V; Rizzo V; Cangialosi C; Musto P; De Rosa L; Liberati AM; Grasso M; Falcone AP; Evangelista A; Cavo M; Gaidano G; Boccadoro M; Palumbo A
Blood; 2010 Dec; 116(23):4745-53. PubMed ID: 20807892
[TBL] [Abstract][Full Text] [Related]
14. The cost-effectiveness of initial treatment of multiple myeloma in the U.S. with bortezomib plus melphalan and prednisone versus thalidomide plus melphalan and prednisone or lenalidomide plus melphalan and prednisone with continuous lenalidomide maintenance treatment.
Garrison LP; Wang ST; Huang H; Ba-Mancini A; Shi H; Chen K; Korves C; Dhawan R; Cakana A; van de Velde H; Corzo D; Duh MS
Oncologist; 2013; 18(1):27-36. PubMed ID: 23299777
[TBL] [Abstract][Full Text] [Related]
15. How to treat elderly patients with multiple myeloma: combination of therapy or sequencing.
Palumbo A; Gay F
Hematology Am Soc Hematol Educ Program; 2009; ():566-77. PubMed ID: 20008241
[TBL] [Abstract][Full Text] [Related]
16. Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial.
Mateos MV; Oriol A; Martínez-López J; Gutiérrez N; Teruel AI; de Paz R; García-Laraña J; Bengoechea E; Martín A; Mediavilla JD; Palomera L; de Arriba F; González Y; Hernández JM; Sureda A; Bello JL; Bargay J; Peñalver FJ; Ribera JM; Martín-Mateos ML; García-Sanz R; Cibeira MT; Ramos ML; Vidriales MB; Paiva B; Montalbán MA; Lahuerta JJ; Bladé J; Miguel JF
Lancet Oncol; 2010 Oct; 11(10):934-41. PubMed ID: 20739218
[TBL] [Abstract][Full Text] [Related]
17. Bortezomib plus melphalan and prednisone for multiple myeloma.
Islam A; Ambrus JL
N Engl J Med; 2008 Dec; 359(24):2613; author reply 2613-4. PubMed ID: 19073984
[No Abstract] [Full Text] [Related]
18. [Therapeutic news in multiple myeloma. Congress of the French National Society of Internal Medicine, December 2008, Bordeaux].
Geffray L
Rev Med Interne; 2009 May; 30(5):465-8. PubMed ID: 19349101
[No Abstract] [Full Text] [Related]
19. Induction therapy for newly diagnosed multiple myeloma.
Lonial S; Miguel JF
J Natl Compr Canc Netw; 2013 Jan; 11(1):19-28. PubMed ID: 23307978
[TBL] [Abstract][Full Text] [Related]
20. A new standard of care in newly diagnosed multiple myeloma.
Richardson PG
Lancet; 2010 Dec; 376(9758):2043-4. PubMed ID: 21146204
[No Abstract] [Full Text] [Related]
[Next] [New Search]
